East Tennessee State University

Digital Commons @ East Tennessee State University
ETSU Faculty Works

Faculty Works

1-1-2014

Deficiency of Ataxia Telangiectasia Mutated Kinase Delays
Inflammatory Response in the Heart Following Myocardial
Infarction
Laura L. Daniel
East Tennessee State University

Christopher R. Daniels
East Tennessee State University

Saghar Harirforoosh
East Tennessee State University, harirfor@etsu.edu

Cerrone R. Foster
East Tennessee State University, fosterc@etsu.edu

Mahipal Singh
East Tennessee State University, singhm@etsu.edu

See next page for additional authors

Follow this and additional works at: https://dc.etsu.edu/etsu-works

Citation Information
Daniel, Laura L.; Daniels, Christopher R.; Harirforoosh, Saghar; Foster, Cerrone R.; Singh, Mahipal; and
Singh, Krishna. 2014. Deficiency of Ataxia Telangiectasia Mutated Kinase Delays Inflammatory Response
in the Heart Following Myocardial Infarction. Journal of the American Heart Association. Vol.3(6).
https://doi.org/10.1161/JAHA.114.001286 ISSN: 2047-9980

This Article is brought to you for free and open access by the Faculty Works at Digital Commons @ East Tennessee
State University. It has been accepted for inclusion in ETSU Faculty Works by an authorized administrator of Digital
Commons @ East Tennessee State University. For more information, please contact digilib@etsu.edu.

Deficiency of Ataxia Telangiectasia Mutated Kinase Delays Inflammatory
Response in the Heart Following Myocardial Infarction
Copyright Statement
© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Creator(s)
Laura L. Daniel, Christopher R. Daniels, Saghar Harirforoosh, Cerrone R. Foster, Mahipal Singh, and
Krishna Singh

This article is available at Digital Commons @ East Tennessee State University: https://dc.etsu.edu/etsu-works/8569

ORIGINAL RESEARCH

Deﬁciency of Ataxia Telangiectasia Mutated Kinase Delays
Inﬂammatory Response in the Heart Following Myocardial Infarction
Laura L. Daniel, BS; Christopher R. Daniels, PhD; Saghar Harirforoosh; Cerrone R. Foster, PhD; Mahipal Singh, PhD; Krishna Singh, PhD

Background-—Ataxia-telangiectasia results from mutations in ataxia telangiectasia mutated kinase (ATM) gene. We recently
reported that ATM deﬁciency attenuates left ventricular (LV) dysfunction and dilatation 7 days after myocardial infarction (MI) with
increased apoptosis and ﬁbrosis. Here we investigated the role of ATM in the induction of inﬂammatory response, and activation of
survival signaling molecules in the heart acute post-MI.
Methods and Results-—LV structure, function, inﬂammatory response, and biochemical parameters were measured in wild-type
(WT) and ATM heterozygous knockout (hKO) mice 1 and 3 days post-MI. ATM deﬁciency had no effect on infarct size. MI-induced
decline in heart function, as measured by changes in percent fractional shortening, ejection fraction and LV end systolic and
diastolic volumes, was lower in hKO-MI versus WT-MI (n=10 to 12). The number of neutrophils and macrophages was signiﬁcantly
lower in the infarct LV region of hKO versus WT 1 day post-MI. Fibrosis and expression of a-smooth muscle actin (myoﬁbroblast
marker) were higher in hKO-MI, while active TGF-b1 levels were higher in the WT-MI 3 days post-MI. Myocyte cross-sectional area
was higher in hKO-sham with no difference between the two MI groups. MMP-9 protein levels were similarly increased in the infarct
LV region of both MI groups. Apoptosis was signiﬁcantly higher in the infarct LV region of hKO at both time points. Akt activation
was lower, while Bax expression was higher in hKO-MI infarct.
Conclusion-—ATM deﬁciency results in decreased dilative remodeling and delays inﬂammatory response acute post-MI. However, it
associates with increased ﬁbrosis and apoptosis. ( J Am Heart Assoc. 2014;3:e001286 doi: 10.1161/JAHA.114.001286)
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A

taxia-telangiectasia (A-T) is a rare autosomal recessive
genetic disorder that causes neurological degeneration.
It is caused by mutations in the gene encoding for ataxia
telangiectasia mutated kinase (ATM).1 This disease affects
approximately 1 in 40 000 births in the United States.2 A-T
individuals are predisposed to the development of cancer,
usually lymphoid cancer. In addition, these individuals suffer
from immunological problems resulting in frequent sinopulmonary infections.2 Both humoral and cell-mediated
immunity are affected, the latter showing itself in the form
of lymphopenia.3 Individuals who are recessive for this
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mutation usually die 7 to 8 years earlier than non-carriers
as a result of either cancer or ischemic heart disease.4
ATM, a 370 kDa protein kinase, is a member of the
phosphatidylinositol 3-kinase-like protein kinase (PIKK) family.
Genotoxic stress, oxidative stress, and growth factors affect
ATM gene expression in various cell types.5,6 ATM is activated
in response to DNA double-strand breaks caused by ionizing
radiation and V(D)J recombination in B and T lymphocyte
development.3 It is also shown to be activated in cells
exposed to hypoxia, insulin, and reactive oxygen species
independent of DNA damage. ATM activation affects cell cycle
checkpoints, apoptotic signaling, senescence, and DNA
repair.7
Myocardial infarction (MI) induces cardiac cell death due to
apoptosis and necrosis, thereby initiating the inﬂammatory
process. Neutrophils are the ﬁrst inﬂammatory cells recruited
to the infarct area.8 Inﬁltration of neutrophils occurs within
hours and peaks 1 to 3 days post-MI.9 Neutrophils facilitate
the post-MI repair process by engulﬁng dead cells and tissue
debris.8 During the inﬂammatory process cytokines such as
TNF-a, IL-1b, and IL-6 are induced.10,11 Neutrophils then
undergo apoptosis generating annexin A1 and lactoferrin,
which inhibits neutrophil recruitment and attracts phagocytic
macrophages to remove neutrophils. Once the macrophages
Journal of the American Heart Association
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Methods
Vertebrate Animals
Downloaded from http://ahajournals.org by on May 3, 2021

This investigation conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85-23, revised 1996). All of the
experiments were performed in accordance with the protocols
approved by the East Tennessee State University Animal Care
and Use Committee. ATM transgenic mice (129xblack Swiss
hybrid background) were purchased from Jackson Laboratory.
Aged-matched (4 month old) male and female mice were
used for the study. The study used heterozygous knockout
(hKO) mice since homozygous knockout (KO) mice die at
2 months of age mainly due to thymic lymphomas.14
Genotyping was performed by PCR using primers suggested
by the Jackson Laboratory.

Myocardial Infarction
Myocardial infarction (MI) was performed as previously
described.13 Brieﬂy, mice were anesthetized using a mixture
of isoﬂurane (2%) and oxygen (0.5 L/min), and maintained
under anesthesia using isoﬂurane (1%) and oxygen (0.5 L/
min). The mice were ventilated using a rodent ventilator. Body
temperature was maintained at 37⁰C using a heating pad.
Heart was exposed by a left thoracotomy followed by the
ligation of left anterior descending artery (LAD) using 7-0
polypropylene suture. Mice in the sham group underwent the
DOI: 10.1161/JAHA.114.001286

same procedure without the ligation of LAD. At the end of the
study period, 1 or 3 days post-MI, isolated hearts were used
for either histology or for molecular analyses.

Echocardiography
Transthoracic 2-dimensional m-mode echocardiography was
performed using a Toshiba Aplio 80 Imaging System (Tochigi,
Japan) equipped with a 12 MHz linear transducer as previously described.15 An individual blinded to the experimental
groups recorded the cardiac structural parameters. A second
individual read the recordings and calculated the functional
parameters of the heart.

Morphometric Analyses
Following MI, hearts were removed and arrested in diastole
using KCl (30 mmol/L). After ﬁxing with 10% buffered formalin,
hearts were cut into 3 transverse sections (base, mid-LV, and
apex) and embedded in parafﬁn. Cross-sections (4 lm think)
were stained using Masson’s Trichrome stain in order to
determine infarct size 3 days post-MI. Infarct size was calculated as the percentage of LV circumference occupied by infarct
scar.13 Infarct size 1 day post-MI was calculated using TTC
stained hearts as previously described.16 Masson’s Trichrome
stained sections were also used to quantify percent ﬁbrosis.

Myocyte Cross-Sectional Area
To measure myocyte cross-sectional area, cross-sections
(4 lm thick) of the heart were stained with FITC-labeled
wheat germ agglutinin (WGA). The sections were visualized
using ﬂuorescent microscopy (20X; Nikon) and images were
recorded using Retiga 1300 color-cooled camera. Suitable
area of the section was deﬁned as the one with nearly circular
capillary proﬁles and nuclei. Myocyte cross-sectional areas
were measured using Bioquant Image analysis software
(Nashville, TN) as described.15

Terminal Deoxynucleotidyl Transferase Nick End
Labeling (TUNEL Staining) Assay
TUNEL staining was carried out according to the manufacturer’s instruction (Cell death detection assay; Roche).13
Sections were counterstained with Hoechst 33258 (Sigma) to
identify nuclei. The index of apoptosis was calculated as the
percentage of apoptotic nuclei/total number of nuclei.

Immunohistochemistry
Cross-sections of the heart (4 lm thick) were deparafﬁnized
and immunostained for neutrophils and macrophages using
Journal of the American Heart Association
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have engulfed the neutrophils, they activate the anti-inﬂammatory pathway by producing molecules such as IL-10 and
TGF-b marking the end of the inﬂammatory phase of infarct
healing and the beginning of the proliferative phase of
healing.12 During the proliferative phase, activated ﬁbroblast
(myoﬁbroblast) produce extracellular matrix proteins aiding in
the scar formation.8 Our previous work examined the role of
ATM in myocardial remodeling post-MI during the proliferative
phase of infarct healing. We reported that ATM deﬁciency
attenuates LV dysfunction and dilatation 7 days post-MI. In
addition, we provided evidence that ATM deﬁciency results in
increased cardiac ﬁbrosis and expression of a-smooth muscle
actin (a-SMA, a marker for myoﬁbroblasts) in the infarct
region 7 days post-MI.13 The objective of this study was to
investigate the role of ATM deﬁciency in cardiac remodeling
during the inﬂammatory phase of infarct healing. A major
ﬁnding of this study is that deﬁciency of ATM associates with
decreased inﬂammatory response and dilative remodeling
early post-MI without affecting infarct size. ATM deﬁciency
also affects apoptosis, ﬁbrosis, expression of proteins
involved in ﬁbrosis and inﬂammation, and activation of
apoptosis-related kinases.
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Western Blot Analyses
LV lysates were prepared in RIPA buffer, separated by SDSPAGE and transferred to PVDF membranes. The membranes
were blocked using either 5% non-fat dry milk or 5% BSA in TBST.
The membranes were then incubated overnight with antibodies
against ATM, TGF-b, Bax (Santa Cruz), MMP-9 (Millipore), Bcl-2,
p-Akt (ser-473), or p-GSK-3b (ser-9) (Cell Signaling). GAPDH
(Santa Cruz) immunostaining or Ponceau-S staining was used
as the protein-loading control. Band intensities were quantiﬁed
using Kodak photo documentation system (Eastman Kodak Co).
Downloaded from http://ahajournals.org by on May 3, 2021

MMP Activity
Gelatin in-gel zymography was used to determine activity of
MMP-9 as previously described.18 Clear digested bands were
quantiﬁed using Kodak photo documentation system (Eastman Kodak Co).

Statistical Analyses
Data are presented as meanSEM: Shapiro-Wilk test was
used to assess the normality of the data. One-way analysis of
variance (ANOVA) or Kruskal-Wallis was used for multiple
comparisons. Pairwise comparisons were carried out using
either Student t test or Mann–Whitney U test (2-sample).
When comparing BW before and after surgery, a 2-tailed
paired t test was used. Survival between the 2 genotypes was
analyzed using Kaplan-Meier survival analysis. Probability (P)
values of <0.05 were considered to be signiﬁcant.

Results
ATM Expression in the Heart Post-MI
To investigate expression of ATM in the heart post-MI, left
ventricular (LV) lysates were prepared from the infarct and
DOI: 10.1161/JAHA.114.001286
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anti-neutrophil (1:100; Santa Cruz) and anti-F4/80 (macrophage; 1:200; Santa Cruz) antibodies, respectively. Detection
was performed using ABC staining system (Santa Cruz).
Sections were counterstained with 1% eosin. Expression of aSMA serves as a marker for the differentiation of ﬁbroblasts
into myoﬁbroblasts.17 To examine expression of a-SMA, heart
sections were immunostained using anti-a-SMA antibodies
(Sigma) as described.13 Images were acquired using Nikon TE2000 microscope equipped with a Regita-1300 color-cooled
camera. Quantitative analysis was carried using Bioquant
Image analysis software (Nashville, TN). At least 5 different
images within the infarct area from each heart were used for
quantitative purposes. Images acquired from the septal wall
represented non-infarct LV region. Images from the sham
group were acquired from various regions around the LV.

1 day post-MI
-ATM
Ponceau

B

3 days post-MI
-ATM
Ponceau

Figure 1. MI increases ATM expression in the heart. LV lysates
prepared from WT-sham, ATM KO, and non-infarct (Non) and
infarct (Inf) LV regions of WT and hKO 1 and 3 days post-MI were
analyzed by Western blot using anti-ATM antibodies. A, 1 day
post-MI; B, 3 days post-MI. Protein loading is indicated by
Ponceau-S staining. ATM indicates ataxia telangiectasia mutated;
hKO, heterozygous knockout; KO, knockout; LV, left ventricle; MI,
myocardial infarction; WT, wild-type.

non-infarct LV regions of WT and hKO 1 and 3 days post-MI.
LV lysate prepared from ATM KO heart served as a negative
control. Western blot analysis using anti-ATM antibodies
showed complete absence of ATM protein (370 kDa) in the
LV lysate prepared from the KO heart (Figure 1A; lane 1). A
faint signal for ATM was observed in WT-sham sample (data
not shown). However, clear signal for ATM protein was
observed in the non-infarct and infarct LV regions of WT and
hKO hearts 1 and 3 days post-MI (Figure 1A and 1B). ATM
protein levels were higher in the infarct LV regions when
compared with the non-infarct LV regions. Overall, ATM
protein levels were lower (50%) in non-infarct and infarct LV
regions of hKO when compared with the WT counterparts.

Morphological Analyses
No signiﬁcant difference in morphometric parameters was
observed between 1- and 3-day sham groups; therefore, 1and 3-day sham groups were pooled. Surgery (sham or MI)
signiﬁcantly decreased body weights (BW) when compared
with the pre-surgery BW with no signiﬁcant differences
between the 2 genotypes. MI increased heart weights (HW)
3 days post-MI in both genotypes with no signiﬁcant difference between the 2 genotypes. HW/BW ratios were significantly higher 1 and 3 days post-MI when compared to their
respective sham with no signiﬁcant differences between the 2
genotypes (Table 1). Infarct sizes between the 2 genotypes
were not different at either 1 day or 3 days post-MI (Table 2).
The survival rate for both genotypes 1 day post-MI was 100%,
Journal of the American Heart Association
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Table 1. Morphometric Measurements
Pre-BW

BW

26.870.82

23.961.11*

HW

HW/BW

124.464.02

4.730.11

Sham
WT (n=11)
hKO (n=11)

*

26.490.68

22.780.77

121.034.78

4.960.21

WT-MI (n=17)

28.381.04

24.211.06*

135.536.98

5.170.23#

hKO-MI (n=11)

26.51.07

24.692.43*

134.015.12

5.610.14#

WT-MI (n=15)

24.930.89

22.280.80*

143.904.91#

6.430.24#

hKO-MI (n=20)

25.390.68

23.070.61*

140.177.51#

6.070.27#

1 day post-MI

3 days post-MI

Values are meanSEM. BW indicates body weight; hKO, heterozygous knockout; HW, heart weight; MI, myocardial infarction; WT, wild-type. *P<0.001 vs pre-BW; #P<0.05 vs Sham.

Table 2. Infarct Size and Myocyte Cross-Sectional Area
Percent Infarct

Cross Sectional Area (mm2)

WT (n=8)

NA

185.065.08

hKO (n=7 to 8)

NA

203.726.64*

WT-MI (n=4 to 7)

32.644.07

213.239.0#

hKO-MI (n=4 to 6)

35.136.08

203.926.19

WT-MI (n=5 to 6)

50.41 2.41

211.367.29#

hKO-MI (n=5 to 7)

51.095.78

204.508.19

Sham

1 day post-MI

3 days post-MI
Downloaded from http://ahajournals.org by on May 3, 2021

Values are meanSEM. hKO, heterozygous knockout; WT, wild-type; MI, myocardial
infarction. #P<0.05 vs Sham, *P<0.05 vs WT-Sham.

while it was 98.4% for WT and 86.2% for hKO 3 days post-MI
with no signiﬁcant difference between the 2 groups.

Echocardiographic Studies
Figure 2A exhibits M-mode echocardiography images
obtained from sham and MI (1 day post-MI) groups. No
signiﬁcant difference in echocardiographic parameters was
observed between 1- and 3-day sham groups. Therefore, 1and 3-day sham groups were pooled. A signiﬁcant decrease
(P<0.05) in heart function, as evidenced by a decrease in
percent fractional shortening (%FS) and ejection fraction (EF),
was observed at 1 and 3 days post-MI in both genotypes
when compared to their respective sham groups. However,
the decrease in %FS and EF was signiﬁcantly lower in hKO-MI
versus WT-MI 1 day post-MI. No signiﬁcant differences in %FS
and EF were observed between the 2 genotypes 3 days postMI (Figure 2B and 2C). Increased LV end-systolic volume
(LVESV) is considered as a predictor of mortality post-MI.19
DOI: 10.1161/JAHA.114.001286

WT-MI group exhibited a signiﬁcant increase in LVESV and LV
end-diastolic volume (LVEDV) 1 and 3 days post-MI when
compared with WT-sham. In hKO-MI, a signiﬁcant increase in
LVESV and LVEDV was observed 1 day, not 3 days, post-MI
when compared with hKO-sham. Interestingly, LVESV and
LVEDV were signiﬁcantly higher in WT-MI versus hKO-MI at
both time points (Figure 2D and 2E).

Inﬂammatory Cell Inﬁltration
Sham groups exhibited the presence of only a few neutrophils
in the heart with no signiﬁcant difference between the 2
genotypes. MI increased the number of neutrophils in the
infarct LV regions of both genotypes at both time points when
compared with their respective sham groups (Figure 3A and
3B). A signiﬁcant increase in neutrophil number was also
observed in the non-infarct LV region of WT group 1 day postMI versus WT-sham (Figure 3A). Interestingly, the number of
neutrophils was signiﬁcantly lower in the infarct and noninfarct LV regions of hKO-MI when compared with WT-MI 1 day
post-MI (Figure 3A). The number of neutrophils in the infarct
LV region decreased signiﬁcantly in both MI groups 3 days
post-MI. However, the number stayed higher in the infarct LV
regions when compared with the sham groups and non-infarct
LV regions in both genotypes. There was no signiﬁcant
difference in the number of neutrophils between the 2
genotypes 3 days post-MI, although the number of neutrophils
in the non-infarct LV region of hKO-MI was signiﬁcantly higher
when compared with hKO-sham (Figure 3B).
Sham groups exhibited the presence of a few macrophages
in the heart with no signiﬁcant difference between the 2
genotypes. MI increased the number of macrophages in the
infarct and non-infarct LV regions of both genotypes when
compared with their respective sham groups. However, the
number of macrophages was signiﬁcantly lower (P<0.05) in
the infarct LV region of hKO-MI versus WT-MI 1 day post-MI
Journal of the American Heart Association
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Figure 2. ATM deﬁciency improves LV function. MI was performed in WT and hKO mice. A, M-mode

Downloaded from http://ahajournals.org by on May 3, 2021

echocardiographic images obtained from sham and 1 day post-MI groups. Indices of cardiac function
(percent fractional shortening, %FS; ejection fraction, EF) and volume (LV end systolic volume, LVESV; LV
end diastolic volume, LVEDV) were calculated using echocardiographic images 1 and 3 days post-MI.
#
P<0.005 vs Sham, *P<0.05 vs WT-MI; n=10 to 12. ATM indicates ataxia telangiectasia mutated; hKO,
heterozygous knockout; LV, left ventricle; MI, myocardial infarction; WT, wild-type.

(Figure 3C). Three days post-MI, the number of macrophages
was still higher in the infarct LV regions of both genotypes
when compared with their respective sham groups, however,
there was no signiﬁcant difference between the 2 genotypes.
In addition, the number of macrophages in the non-infarct LV
region of hKO-MI was signiﬁcantly higher when compared with
hKO-sham (Figure 3D).

Fibrosis, Apoptosis, and Myocyte Cross-Sectional
Area
Quantitative analysis of ﬁbrosis using Masson’s Trichromestained sections revealed no change in ﬁbrosis between 1- and
3-day sham groups, therefore the sham groups were pooled.
The amount of ﬁbrosis was signiﬁcantly higher in hKO-sham
versus WT-sham. MI increased ﬁbrosis in the infarct LV region
of both groups 3 days post-MI. However, the amount of ﬁbrosis
was signiﬁcantly higher in hKO-MI versus WT-MI (Figure 4).
Only a few apoptotic cells were detected in the sham and
non-infarct LV regions of WT-MI and hKO-MI 1 day post-MI. MI
signiﬁcantly increased the number of apoptotic cells in the
infarct LV region of both genotypes 1 day post-MI (Figure 5A).
However, the number of apoptotic cells was signiﬁcantly
DOI: 10.1161/JAHA.114.001286

greater in the hKO-MI (P<0.05) versus WT-MI. Three days
post-MI, the level of apoptosis in the infarct LV regions
decreased in both genotypes versus 1 day post-MI. However,
it remained higher when compared with their respective sham
groups and non-infarct LV regions (Figure 5B). Interestingly,
hKO-MI continued to have a signiﬁcantly higher number of
apoptotic cells (P<0.05) in the infarct LV region versus WT-MI.
hKO-MI also exhibited a signiﬁcant increase (P<0.05) in
apoptosis in the non-infarct LV region when compared with
hKO-sham and non-infarct WT-MI.
Myocyte cross-sectional area was signiﬁcantly higher in
hKO-sham group versus WT-sham. Myocyte cross-sectional
area in the non-infarct LV region remained unchanged in the
hKO-MI group 1 and 3 days post-MI. However, a signiﬁcant
increase in myocyte cross-sectional area was observed in WTMI group when compared with WT-sham 1 and 3 days post-MI
(Table 2).

Expression of TGF-b1
The anti-inﬂammatory cytokine TGF-b1 plays an important
role in myocardial remodeling post-MI via its involvement in
the differentiation of ﬁbroblasts into myoﬁbroblasts and ECM
Journal of the American Heart Association
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Figure 3. ATM deﬁciency results in decreased inﬂammatory cells in the infarct LV region 1 day
post-MI. Cross-sections of the heart post-MI were immunostained using anti-neutrophil (A and B) and
anti-F4/80 (macrophage; C and D) antibodies. The number of immune-positive cells was quantiﬁed
using Bioquant Image analysis software. Quantitative analyses of neutrophils 1 (A) and 3 (B) days postMI. Quantitative analyses of macrophages 1 (C) and 3 (D) days post-MI. #P<0.05 vs Sham, $P<0.05 vs
Non, *P<0.05 vs WT; n=4 to 6. ATM indicates ataxia telangiectasia mutated; hKO, heterozygous
knockout; Inf, infarct; LV, left ventricle; MI, myocardial infarction; WT, wild-type.
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% Fibrosis
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WT-MI

deposition.8 One source of TGF-b1 is macrophages as they
phagocytose apoptotic neutrophils.12 Western blot analysis
showed no presence of active TGF-b1 protein (23 kDa band)
in the sham groups, non-infarct or infarct LV regions 1 day
post-MI (data not shown). Presence of active TGF-b1 band
was only observed in the infarct LV regions of both genotypes
3 days post-MI. However, the levels of active TGF-b1 were
signiﬁcantly higher in the WT-MI versus hKO-MI (Figure 6).

8

#

6
4
2
0

*

Figure 4. ATM deﬁciency results in increased ﬁbrosis.
Masson’s trichrome stained sections of the heart were used
for quantitative measurement of ﬁbrosis. Upper panel depicts
Masson’s trichrome-stained sections exhibiting ﬁbrosis in WT
and hKO hearts 3 days post-MI. Lower panel exhibits
quantitative analysis of ﬁbrosis. #P<0.05 vs Sham, *P<0.05
vs WT-MI; n=5 to 6. ATM indicates ataxia telangiectasia
mutated; hKO, heterozygous knockout; Inf, infarct; MI,
myocardial infarction; WT, wild-type.

DOI: 10.1161/JAHA.114.001286

Expression of a-Smooth Muscle Actin (a-SMA)
Increased a-SMA expression is considered as a marker for the
differentiation of ﬁbroblasts into myoﬁbroblast.20 One day
post-MI, little to no expression of a-SMA expression was
observed in the infarct LV regions of either group (data not
shown). Three days post-MI, a signiﬁcant increase in a-SMA
expression was observed in the infarct LV region of both
genotypes when compared with their respective sham groups.
However, the increase in a-SMA expression was signiﬁcantly
higher (P<0.05) in hKO-MI versus WT-MI (Figure 7).

Expression and Activity of MMP-9
MMP-9 regulates the remodeling processes of the heart that
involves inﬂammation and ﬁbrosis.21 MMP-9 levels in the
Journal of the American Heart Association
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Figure 5. ATM deﬁciency results in enhanced apoptosis post-MI. Quantitative analysis of cardiac cell
apoptosis in the non-infarct (Non) and infarct (Inf) LV regions 1 (A) and 3 (B) days post-MI. Upper panels
depict TUNEL-stained and Hoechst-stained images obtained from WT and hKO hearts 1 and 3 days post-MI.
Red ﬂuorescent staining indicates TUNEL-positive (apoptotic) nuclei, while blue ﬂuorescent staining
indicates total number of nuclei. The lower panels exhibit quantitative analysis. #P<0.05 vs Sham *P<0.05
vs WT, $P<0.05 vs Non; n=4 to 6. ATM indicates ataxia telangiectasia mutated; hKO, heterozygous
knockout; Inf, infarct; LV, left ventricle; MI, myocardial infarction; WT, wild-type.
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ischemic region of the heart increase within minutes after MI
and stay higher during the ﬁrst few days in animal
models.21,22 Western blot analysis revealed increased MMP9 protein levels in the infarct LV regions of both genotypes
1 day post-MI when compared with their respective sham
groups. However, no signiﬁcant differences were observed
between the 2 genotypes (Figure 8A). MMP-9 expression
remained higher in the infarct LV regions of both genotypes
3 days post-MI with no signiﬁcant difference between the 2
genotypes (Figure 8B). In-gel zymography revealed increased
MMP-9 activity in the infarct LV regions of both genotypes
(data not shown).

Activation and Expression of Apoptosis-Related
Proteins
Increased phosphorylation (activation) of Akt is generally
considered as an anti-apoptotic signal.23 Phosphorylation of
Akt remained unchanged in the WT-MI 1 day post-MI.
However, Akt phosphorylation was signiﬁcantly lower in the
non-infarct and infarct LV regions of hKO-MI versus hKOsham. In addition, Akt phosphorylation was signiﬁcantly lower
in the hKO-MI infarct LV region versus WT-MI infarct LV region
DOI: 10.1161/JAHA.114.001286

(Figure 9A). No signiﬁcant change in Akt phosphorylation was
observed among the groups 3 days post-MI (data not shown).
Activation of GSK-3b plays a pro-apoptotic role in badrenergic receptor-stimulated apoptosis.24 Phosphorylation
of N-terminal serine-9 inactivates GSK-3b.25 GSK-3b phosphorylation (serine-9) was lower in the non-infarct LV region of
WT-MI versus WT-sham 1 day post-MI. In the infarct LV
region, hKO-MI exhibited a signiﬁcant decrease in GSK-3b
phosphorylation when compared to hKO-sham and WT-MI
infarct LV region (Figure 9B). Three days post-MI, GSK-3b
phosphorylation was signiﬁcantly lower (P<0.05) in infarct and
non-infarct region of both WT and hKO mice when compared
with their respective sham groups with no signiﬁcant
difference between the 2 MI groups (data not shown).
Bax, a pro-apoptotic protein, is a transmembrane protein
located in the outer mitochondrial membrane. Homodimerization of Bax increases cytochrome c release resulting in the
induction of apoptosis. Bcl-2 can inhibit Bax induced apoptosis by forming a heterodimer with Bax.26 Western blot
analyses showed no difference in Bax or Bcl-2 protein levels
between the 2 genotypes in the infarct LV regions 1 day postMI (data not shown). Bax expression was signiﬁcantly higher
in the infarct LV region of hKO when compared to WT group
Journal of the American Heart Association
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3 days post-MI. However, there was no signiﬁcant difference
in Bcl2 expression between the 2 genotypes 3 days post-MI
(Figure 10).

Discussion
Previously we provided evidence that ATM deﬁciency results
in improved heart function and decreased LV dilatation 7 days
post-MI. A major ﬁnding of this study is that ATM deﬁciency
associates with delayed inﬂammatory response post-MI. This
is evidenced by the decreased number of neutrophils and
macrophages 1 day post-MI, and decreased expression of
TGF-b1 in the infarct area 3 days post-MI. ATM deﬁciency
also associated with increased apoptosis, ﬁbrosis and
expression of a-SMA in the heart post-MI. Activation of prosurvival kinase, Akt, was lower, while activation of proapoptotic kinase, GSK-3b, was higher in ATM deﬁcient hearts
1 day post-MI. The data presented here support our previous
ﬁndings,13 and suggest multifaceted role of ATM in myocardial remodeling post-MI.
ATM normally becomes activated in response to DNA
damage, particularly due to the formation of DNA doublestrand breaks. This activation occurs due to its autophosphorylation on Ser1981.27 Genotoxic agents, oxidative stress and
growth factors also increase ATM expression in certain cell
DOI: 10.1161/JAHA.114.001286

0.00

Figure 7. Quantitative analysis of a-smooth muscle actin (aSMA) expression. Cross-sections of the heart were
immunostained using anti-a-SMA antibodies. Upper panel depicts
a-SMA-stained images from the infarct (Inf) LV regions of WT and
hKO hearts 3 days post-MI. Lower panel exhibits quantitative
immunocytochemical analysis of a-SMA in sham and Inf LV
regions 3 days post-MI. #P<0.05 vs Sham, *P<0.05 vs WT-Inf;
n=4 to 5. hKO indicates heterozygous knockout; LV, left ventricle;
MI, myocardial infarction; WT, wild-type.

types.5,6 In peripheral blood mononuclear cells, maximum
increase in ATM expression in response to mitogenic stimuli
was observed 3 to 4 days after exposure.6 Previously, we
have shown that b-AR stimulation increases ATM expression
in adult rat ventricular myocytes and heart.28 This study
provides evidence that MI increases ATM expression in the
heart. The increase in ATM could be a result of either
increased sympathetic nerve activity and/or increased oxidative stress, both of which increase in the heart following
MI.29,30
MI usually leads to increased chamber diameter which
results in increased loading capacity of the heart represented
by increased LVESV and LVEDV. Increased LVESV is suggested as one of the major determinants of survival post-MI.19
Previously, we provided evidence that deﬁciency of ATM
attenuates LV dysfunction and dilatation 7 days post-MI.13
The data presented here suggest that the attenuation of LV
dysfunction and dilation during ATM deﬁciency can be
observed as early as 1 day post-MI. ATM deﬁcient mice
exhibit a lesser degree of impairment in systolic parameters
as evidenced by higher %FS and EF 1 day post-MI. It was
interesting to note that %FS and EF were not different
between the 2 genotypes 3 days post-MI, although LVESV
Journal of the American Heart Association

8

ATM and Myocardial Infarction

Daniel et al

WT hKO

WT hKO

WT hKO

Sham

Non

Inf

-MMP-9
-GAPDH

B
WT hKO WT hKO WT hKO

Sham

#

8

4

Inf

#

MMP-9 (fold change vs
WT-Sham)

#
12

Non

4

WT
hKO

16

MMP-9 (fold Change vs WTSham)

ORIGINAL RESEARCH

-MMP-9
-GAPDH

A

0

3

#
2

1

0
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and LVEDV were signiﬁcantly lower in ATM-deﬁcient hearts at
both time points. The better LV function 1 day post-MI during
ATM deﬁciency did not correlate with infarct size since infarct
sizes remained unchanged between the 2 genotypes 1 and
3 days post-MI. Other factors such as infarct thickness,
myocardial ﬁbrosis, and myocyte hypertrophy also inﬂuence

-pGSK-3β
-GAPDH
hKO

1.2
1.0

#
0.8
0.6

#*

0.4
0.2
0.0

Figure 9. Phosphorylation of Akt and GSK-3b. Total LV lysates, prepared from sham, non-infarct (Non)
and infarct (Inf) LV regions 1 day post-MI, were analyzed by Western blot using phospho-speciﬁc antibodies
for Akt (ser-473) and GSK-3b (ser-9). The upper panels depict autoradiograms indicating immunostaining
for p-Akt, p-GSK-3b and GAPDH. The lower panels exhibit quantitative analyses of p-Akt (A) and p-GSK-3b
(B) normalized to GAPDH. #P<0.05 vs Sham; *P<0.05 vs WT-Inf; n=6. GSK, glycogen synthase kinase; hKO
indicates heterozygous knockout; LV, left ventricle; MI, myocardial infarction; WT, wild-type.
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unchanged between the 2 genotypes 1 and 3 days post-MI.
Expression of a-SMA was higher in ATM deﬁcient hearts
3 days post-MI. Therefore, slightly better function exhibited
by ATM deﬁcient hearts 1 day post-MI cannot be explained by
infarct thickness or expression of a-SMA. ATM deﬁciency
associates with increased myocyte cross-sectional area and
ﬁbrosis at basal levels, and results in delayed inﬂammatory
response post-MI. Therefore, myocyte hypertrophy, myocardial ﬁbrosis and delayed inﬂammatory response may help
explain better function during ATM deﬁciency 1 day post-MI.
Neutrophils begin to inﬁltrate into the infarcted myocardium within hours of the ischemic event peaking 24 hours
post-MI.9 Neutrophil inﬁltration activates resident monocytes
to differentiate into macrophage in the infarct LV region
shortly after MI. Macrophage number stays relatively stable
from 1 to 7 days post MI.12 Macrophages play a number of
roles in post-MI healing process. They phagocytose dead
cells, tissue debris, and apoptotic neutrophils. In addition,
they secret MMPs and their inhibitors to aid in extracellular
matrix reorganization.12 Consistent with these data, we
observed increased number of neutrophils and macrophages
in the myocardium of both genotypes at both time points.
Interestingly, the number of inﬂammatory cells was signiﬁcantly lower in ATM-deﬁcient hearts 1 day post-MI. Three
days post-MI, the number of neutrophils decreased, while the
number of macrophages increased in the infarct LV regions of
both genotypes. However, the number of neutrophils and
macrophages was not signiﬁcantly different between the 2
genotypes. These data suggest a delayed inﬂammatory
response during ATM deﬁciency early post-MI. Neutrophils
DOI: 10.1161/JAHA.114.001286

are recruited to the site of inﬂammation via chemokines and
cytokines.8 However, signals such as lactoferrin and annexin
1 released by apoptotic cells can inhibit recruitment of
neutrophils to the site of the injury.33,34 ATM-deﬁcient hearts
exhibit increased apoptotic response when compared with
their WT counterparts. This increase in apoptosis during ATM
deﬁciency can have an inhibitory effect on neutrophil
migration. A decrease in inﬂammatory receptors (selectins,
integrins, and adhesion receptors) may also inﬂuence neutrophil recruitment.35 Further investigations are required to
investigate the involvement of these molecular signals in the
inﬂammatory response in the heart post-MI during ATM
deﬁciency.
Phagocytosis of neutrophils by macrophages initiates the
release of anti-inﬂammatory signal involved in resolution of
inﬂammation.12 Suppression of inﬂammatory response may
involve a variety of signals, including a secreted protein TGFb. TGF-b1, an anti-inﬂammatory signal, can affect infarct
healing by modulating the release of cytokines and chemokines, synthesis of ECM proteins and transdifferentiation of
ﬁbroblasts into myoﬁbroblasts.36 In rat MI model, increased
expression of TGF-b1 mRNA was observed 3 days post-MI.37
Here we observed increased levels of active TGF-b1 in the
heart 3 days post-MI. ATM deﬁciency associated with
decreased macrophage count 1 day post-MI and decreased
active TGF-b1 levels 3 days post-MI. This is consistent with
the fact that macrophages are a major producer of TGF-b
post-MI.8 It is interesting to note that ATM deﬁciency also
associates with increased expression of a-SMA and ﬁbrosis
3 days post-MI. While TGF-b is a known activator of ﬁbroblast
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stimulation.15 However, b-AR stimulation had no effect on
GSK-3b activation during ATM deﬁciency. Collectively, these
data suggest activation of Akt, via ATM, as a common
signaling event during myocardial stress. Activation of GSK-3b
appears to be modulated differentially in response to different
myocardial stress during ATM deﬁciency.
In summary, ATM deﬁciency results in improved heart
function as determined by a decrease in dilative remodeling
and inﬂammatory response acute post-MI. However, it also
associates with negative remodeling as determined by
increased apoptosis and decreased activation of anti-apoptotic kinase, Akt. In addition, ATM deﬁciency results in an
increase in ﬁbrosis and expression of a-SMA. These studies,
together with our previous ﬁndings,13 suggest that ATM has
the potential to modulate the remodeling processes of the
heart post-MI. Further investigations are needed to deﬁne the
long-term impact of ATM deﬁciency in the healing processes
of the heart post-MI.
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